Famotidine
- Product NDC
- 70860-752
- 11-digit product format
- 708600752
- Labeler code
- 70860
- Product ID
- 70860-752_546575de-cef0-45ca-a440-2a3d8d34fdc9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- famotidine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA075651
- Marketing category
- ANDA
- Marketing start
- 2020-08-10
- Marketing end
- 0000-00-00
- Substance
- FAMOTIDINE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70860-752-04 | Famotidine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | | 5 |
| 70860-752-41 | Famotidine | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-752 | FAMOTIDINE INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 5 | Legacy NDC, 2 package rows | 20250130_234d941f-5754-4d83-b02e-26638e0054e6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-752-04 | 70860075204 | 10 VIAL in 1 CARTON (70860-752-04) > 4 mL in 1 VIAL (70860-752-41) | 10 vial | 2020-08-10 | 0000-00-00 | No | No | Current |
| 70860-752-41 | 70860075241 | 4 mL in 1 VIAL | 4 ml | | | | | Historical |